Diabetes is now one of the biggest health problems facing America; according to a recent report from the Centers for Disease Control and Prevention (CDC) approximately 29.1 million Americans (9.3 percent of the population) currently have diabetes. Rimidi is a new health startup focusing exclusively on fighting diabetes with its diabetes management and health population software. The company recently received a strategic investment of an undisclosed amount from media conglomerate Cox Enterprises, an indicator of the industry’s rising confidence in Rimidi’s solution.
“We are thrilled to receive this investment from Cox Enterprises, a company that embraces innovation and collaboration and is helping shape the future of healthcare,” said Lucienne Ide, Rimidi CEO. “The funding will allow us to accelerate the expansion of our solution that helps physicians and patients better manage chronic diseases.”
Diabetes+Me, Rimidi’s flagship product, is a cloud-based platform that provides patients and healthcare providers with extensive tools for effectively managing diabetes and minimizing disruptions to daily life as well as access to educational materials. The solution works to address many of the current problems facing diabetes management including a lack of patient communication and engagement, a lack of adequate data and delayed outcomes toward health goals as well as the related effects such as patients’ and providers’ frustration, wasted money and lost time. As a comprehensive critical software platform, Diabetes+Me bridges the gap between patients and providers and enables them to work together to solve these problems.
Diabetes+Me pairs with glucometers to provide straightforward access to glucose readings and offers tracking of other health metrics such as nutrition, exercise and stress levels. This data is then transferred to providers who can use it to formulate ideal treatment options, predict the outcomes of various treatments and quickly adapt to changes in a patient’s health or lifestyle. For example, a doctor can determine with considerable accuracy whether a medication change or behavioral change in something like diet or exercise would be more appropriate for effectively treating a patient. These insights are shared with the patient so both parties can work toward an optimized plan for managing diabetes.
Rimidi plans to use the funds from Cox Enterprises’ investment to expand into additional markets and foster more collaborative opportunities. Cox Enterprises is apparently interested in growing its presence in the healthcare industry: this announcement follows a partnership with Cleveland Clinic to form Vivre Health — a healthcare company specializing in telehealth and home health solutions — and an investment in telehealth technology provider HealthSpot earlier this year.
“Cox Enterprises is excited to work with Rimidi,” said Alex Taylor, Cox Enterprises' executive vice president. “We like supporting local entrepreneurs like Lucie, and we are excited to see her transforming our healthcare system for the better. Data and analytics will help our communities be healthier and happier – some of the same reasoning that led us to invest in HealthSpot and set up Vivre, a joint venture with Cleveland Clinic.”
Edited by
Dominick Sorrentino
